Regulatory & Beyond 2026


Monday, 16 November 2026, Kursaal Bern

“Regulatory & Beyond” is back: The Swissmedic event brings together experts from medicinal product authorisation and the regulatory environment in Switzerland. The focus is on developments, challenges and perspectives that are relevant for companies, authorisation holders and authorities.

At the stands at the Swissmedic Market, you will be able to gain insights into our various divisions and groundbreaking projects during the lunch break and at the drinks reception at the end of the event:

  • Meet your Regulatory Manager/Regulatory Associate

  • Clinical Assessment Division

  • Quality Assessment Division

  • Regulatory Operations and Development Division

  • Complementary and Herbal Medicines

  • Veterinary Medicines Division

  • Clinical Trials Division

  • Stakeholder Engagement



Administrative information

  • Language: All speakers will be giving their presentation in their native language (according to the programme). The presentations will be shown in the language in which they are given and in English (no simultaneous translation).

  • Event type: The event will only take place at the venue. It will not be streamed and you will not be able to attend online.

  • Participation fee: CHF 750.00

  • Presentations: The presentations will be available on the Swissmedic website in German and English after the event. A link will be e-mailed to all participants.

  • Certificate of participation: After the event, all participants will receive a link to download their personal certificate of participation.

  • Registration: Now open; please use the registration form on this page

Agenda

Welcome coffee and registration

Welcome and start of the event Opening presentation “Swissmedic under one roof”

Vincenza Trivigno
Executive Director Swissmedic

Medicinal Product Authorisation and Vigilance

We are consolidating all medicinal product groups and harnessing synergies

Eveline Trachsel
Head of Medicinal Product Authorisation and Vigilance Sector Swissmedic

Good Regulatory Practice

Recommendations for efficient application processing

Sandra Zaugg
Deputy Head of Medicinal Product Authorisation and Vigilance Sector Swissmedic

Coffee break

Swissmedic measures to improve security of supply

Simon Dalla Torre
Head of Regulatory Operations and Development Division

Innovations in reporting tools (ElViS 2.0) and risk communication

Stephanie Storre
Head of Risk Management Division

Thomas Stammschulte
Head of Pharmacovigilance Division

Cooperation instead of isolation

Life cycle management in international regulatory networks

Ulla Grauschopf
Head of Quality Assessment Division

Lunch break with buffet lunch & Swissmedic Market

With stands on/from the following subjects/Divisions:

  • Regulatory Assessement, Meet your Regulatory Manager

  • Clinical Assessment

  • Quality Assessment

  • Regulatory Operations and Development

  • Complementary and Herbal Medicines

  • Veterinary Medicinal Products

  • Safety of Medicines

  • Stakeholder Engagement

  • Clinical Trials

Session «Beyond»

Session «Beyond»

Raum Arena


14:00-14:45 Uhr

Most Favored Nation: Who Will Finance Pharmaceutical Research and Development in the Future?

Stefan Felder
Professor of Health Economics, University of Basel, Faculty of Business and Economics


14:45-15:05 Uhr

Update IT-Roadmap; Preview Portal Swissmedic

Ulrich Vogler
Head of Infrastructure Informatics


15:05-16:05 Uhr

Swissmedic’s role as an autonomous, neutral regulatory authority in the international environment


Input presentation

Kerstin Noëlle Vokinger
Professor at the University of Zurich & ETH Zurich


Panel Discussion

Moderation: Eveline Trachsel

  • Vincenza Trivigno, Executive Director Swissmedic

  • Stefan Hostettler, Joint General Secretary, Department of Home Affairs DHA

  • Kerstin Noëlle Vokinger, Professor at the University of Zurich & ETH Zurich

  • David Traub, Managing Director of Novartis Switzerland

  • Yvonne Gilli, President of FMH

  • Enea Martinelli, Head Pharmacist of Spitäler fmi AG, VP pharmaSuisse, drug shortage specialist

16:05-16:10 Uhr

Closing Remarks

Eveline Trachsel

Session “Veterinary medicinal products”

Breakout session “Veterinary medicinal products”

Szenario 1 room

Please note that all presentations and lectures will be given in German only.


14:00-14:15

Begrüssung

Nina Walser
Leiterin Abteilung Tierarzneimittel, Swissmedic


14:15-14:45
Evergreens im Regulatory Assessment Tierarzneimittel: Die Do’s & Don’ts, die zählen

Alexandre Scherer
Regulatory Manager, Abteilung Tierarzneimittel, Swissmedic


14:45-15:15
Regulatory Intelligence in der Schweiz: Das passende Zulassungsverfahren für jedes Tierarzneimittel – besser entscheiden, schneller zulassen

Catharina Lany
Senior Regulatory Manager, Abteilung Tierarzneimittel, Swissmedic


15:15-15:45
Evergreens Pharmakovigilanz Tierarzneimittel: Behind the Scenes der Arzneimittelsicherheit

Cedric Müntener
Veterinary Assessor, Abteilung Tierarzneimittel, Swissmedic


15:45-16:10
Fragerunde

Drinks reception & Swissmedic Market

Mit Ständen zu folgenden Themen und Abteilungen:

With stands on/from the following subjects/Divisions:

  • Regulatory Assessment, meet your Regulatory Manager

  • Clinical Assessment (incl. ATMPs)

  • Quality Assessment (incl. ATMPs)

  • Regulatory Operations and Development

  • Complementary and Herbal Medicines

  • Veterinary Medicinal Products

  • Safety of Medicines

  • Clinical Trials·

  • Stakeholder Engagement

End of the event

Registration

Venue

Kursaal Bern

Kornhausstrasse 3, Bern
3013 Bern

Contact

If you have any questions, please contact our event team: events@swissmedic.ch